Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market
Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market Orion Pharma (“Orion”) and Shilpa Biologicals Private Limited, a fully-owned subsidiary of Shilpa Medicare Limited…
Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat (NASDAQ:AAPG) is one of the best biotech stocks on this list. TheFly reported on June 15 that Oppenheimer initiated coverage of…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
This marks the fourth R&D milestone achieved under the collaboration, and the second in 2026, reflecting the steady progress of development under the collaboration Under the terms of the agreement, Nxera is eligible to receive up to US$1.2 billion…
Big Pharma Has a Case of Merger Mania
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Matt Frankel, and Lou Whiteman take a dive into what's driving the merger-and-acquisition frenzy, including: Big pharma is using big wallets for M&A. Who's…
Aurobindo Pharma completes acquisition of US-based Lannett Company
, an arm of Aurobindo Pharma, completed the previously announced acquisition of Lannett Company, Inc., USA from Lannett Seller Holdco, Inc. On June 18, 2026, Aurobindo received approval from the US Federal Trade Commission for the acquisition.
CCI closes anti-competitive practices case against druggists' body, pharma companies
Fair trade regulator CCI on Monday closed a long-running probe into alleged anti-competitive practices against AIOCD, its affiliated associations and several pharma companies, after finding no violation of competition law. The case pertained to…
Apollo's top economist warns of a painful market repricing as return on AI investment slows
Uneven returns on AI investment could be a wakeup call for the red-hot stock market, a top economist says. US equities are roaring, with unrelenting tech bullishness putting the the Nasdaq 100 on track for its best quarter in years. Yet, Torsten…
Hsbc Holdings PLC Cuts Stock Holdings in Royalty Pharma PLC $RPRX
Hsbc Holdings PLC lowered its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 75.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 57,998 shares of the…
New UK antibiotics alert as 'defect' notice issued
A new warning has been issued for a type of penicillin used across the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) announced in a new 'Class 4 Medicines Defect Notification' that Brancaster Pharma Limited had notified it that…
Kairos Meridian Launches an Independent, Shorter Path From Problem to Impact
Most commercial programs are still measured for activity rather than impact. Brand teams are held to tangible results while being pressured to do more with less. Too often they are left choosing between large agencies that add unnecessary…
Hong Kong draws royalties giant as mainland China biotech licensing heats up
The world's largest buyer of biopharmaceutical royalties has set up its first Asia-Pacific base in Hong Kong, joining a string of multinational corporations in the pharmaceutical sector establishing offices in the city as out-licensing deals by…
BridgeBio: 3 New Drug Approvals In Sight Outweigh Attruby Issues, Still Bullish (BBIO)
BridgeBio Pharma, Inc. remains a Buy, driven by Attruby's commercial launch and a robust late-stage pipeline targeting rare genetic diseases. BBIO's $14bn+ valuation is underpinned by four potential blockbuster drugs by 2030, with key NDA catalysts…
Ro Khanna for Re-Election to Congress - Our Revolution
For nearly a decade in Congress, Rep. Ro Khanna has proven that bold progressive leadership can deliver real results. That's why Our Revolution is proud to endorse Ro Khanna for re-election to represent California's 17th Congressional District. Ro…
French biotech stock soars 31% after new data on experimental medicine
The late-stage clinical trial data of the medicine, released late on Monday, showed that malignancies were in line with expected background rates. Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug…
Micron And The Price Of Certainty (NASDAQ:MU)
Micron Technology, Inc. shifts to a partially contracted business model, with SCAs covering over half of future revenue and improving visibility. SCAs provide downside protection via floor prices but limit upside with ceilings, complicating…
Receive a Daily briefing on Pharma Industry News
Get Started